EBS
Price
$7.17
Change
-$0.30 (-4.02%)
Updated
Jul 25 closing price
Capitalization
120.07M
10 days until earnings call
INDV
Price
$17.14
Change
+$0.33 (+1.96%)
Updated
Jul 25 closing price
Capitalization
2.91B
4 days until earnings call
Interact to see
Advertisement

EBS vs INDV

Header iconEBS vs INDV Comparison
Open Charts EBS vs INDVBanner chart's image
Emergent Biosolutions
Price$7.17
Change-$0.30 (-4.02%)
Volume$788.62K
Capitalization120.07M
Indivior
Price$17.14
Change+$0.33 (+1.96%)
Volume$5.04M
Capitalization2.91B
EBS vs INDV Comparison Chart in %
Loading...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EBS vs. INDV commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EBS is a Hold and INDV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (EBS: $7.17 vs. INDV: $17.14)
Brand notoriety: EBS and INDV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EBS: 73% vs. INDV: 264%
Market capitalization -- EBS: $120.07M vs. INDV: $2.91B
EBS [@Pharmaceuticals: Other] is valued at $120.07M. INDV’s [@Pharmaceuticals: Other] market capitalization is $2.91B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EBS’s FA Score shows that 1 FA rating(s) are green whileINDV’s FA Score has 0 green FA rating(s).

  • EBS’s FA Score: 1 green, 4 red.
  • INDV’s FA Score: 0 green, 5 red.
According to our system of comparison, EBS is a better buy in the long-term than INDV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EBS’s TA Score shows that 2 TA indicator(s) are bullish while INDV’s TA Score has 4 bullish TA indicator(s).

  • EBS’s TA Score: 2 bullish, 5 bearish.
  • INDV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INDV is a better buy in the short-term than EBS.

Price Growth

EBS (@Pharmaceuticals: Other) experienced а +3.46% price change this week, while INDV (@Pharmaceuticals: Other) price change was +7.06% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

EBS is expected to report earnings on Aug 06, 2025.

INDV is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDV($2.91B) has a higher market cap than EBS($120M). INDV has higher P/E ratio than EBS: INDV (2102.00) vs EBS (17.73). INDV YTD gains are higher at: 37.892 vs. EBS (-25.000). INDV has higher annual earnings (EBITDA): 66M vs. EBS (-518.2M). INDV has more cash in the bank: 410M vs. EBS (112M). INDV has less debt than EBS: INDV (282M) vs EBS (860M). INDV has higher revenues than EBS: INDV (1.09B) vs EBS (1.02B).
EBSINDVEBS / INDV
Capitalization120M2.91B4%
EBITDA-518.2M66M-785%
Gain YTD-25.00037.892-66%
P/E Ratio17.732102.001%
Revenue1.02B1.09B94%
Total Cash112M410M27%
Total Debt860M282M305%
FUNDAMENTALS RATINGS
EBS vs INDV: Fundamental Ratings
EBS
INDV
OUTLOOK RATING
1..100
1345
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
10054
SMR RATING
1..100
9477
PRICE GROWTH RATING
1..100
6138
P/E GROWTH RATING
1..100
1198
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EBS's Valuation (56) in the Biotechnology industry is somewhat better than the same rating for INDV (100) in the null industry. This means that EBS’s stock grew somewhat faster than INDV’s over the last 12 months.

INDV's Profit vs Risk Rating (54) in the null industry is somewhat better than the same rating for EBS (100) in the Biotechnology industry. This means that INDV’s stock grew somewhat faster than EBS’s over the last 12 months.

INDV's SMR Rating (77) in the null industry is in the same range as EBS (94) in the Biotechnology industry. This means that INDV’s stock grew similarly to EBS’s over the last 12 months.

INDV's Price Growth Rating (38) in the null industry is in the same range as EBS (61) in the Biotechnology industry. This means that INDV’s stock grew similarly to EBS’s over the last 12 months.

EBS's P/E Growth Rating (11) in the Biotechnology industry is significantly better than the same rating for INDV (98) in the null industry. This means that EBS’s stock grew significantly faster than INDV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EBSINDV
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
58%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 3 days ago
71%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 7 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
72%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EBKDY46.260.12
+0.26%
Erste Group Bank AG
CMUV24.10N/A
N/A
CMUV Bancorp
GRVWF0.28N/A
N/A
Greatview Aseptic Packaging Company Ltd.
NPTLF10.00N/A
N/A
NORTHAM PLATINUM HLDGS LTD.
FMCCH17.58-1.17
-6.24%
Freddie Mac

EBS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EBS has been loosely correlated with AMRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if EBS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EBS
1D Price
Change %
EBS100%
-4.02%
AMRX - EBS
39%
Loosely correlated
+0.75%
HROW - EBS
39%
Loosely correlated
-2.81%
SIGA - EBS
34%
Loosely correlated
+1.13%
HKMPF - EBS
34%
Loosely correlated
N/A
VTRS - EBS
33%
Loosely correlated
+0.64%
More

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and EBS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
+1.96%
EBS - INDV
28%
Poorly correlated
-4.02%
COLL - INDV
28%
Poorly correlated
-1.03%
VTRS - INDV
25%
Poorly correlated
+0.64%
ALKS - INDV
25%
Poorly correlated
-1.51%
ELAN - INDV
25%
Poorly correlated
+1.57%
More